By Amilynne Eddington, Director of Laboratory Operations, Lumea Ask anyone who has spent time in an anatomic pathology lab, and they will tell you the same thing: prostate core biopsies…
Read More
Recognition places Lumea among elite global winners including Medtronic and Thermo Fisher Scientific in one of digital health’s most competitive annual programs LEHI, UT, UNITED STATES, May 14, 2026 /…
A prostate cancer diagnosis is not the end of a patient’s clinical story, it’s the beginning of a series of decisions that will define a patient's treatment trajectory. Active surveillance...
Read More
Pathology has remained largely static for over a century: tissue fixed on glass, glass mounted on a microscope stage, and a pathologist confined to a physical office. Digital pathology disrupts…
